It is apparent that the professional research subject is not unique to early phase trials and that an effective clinical trials database registry must include all phases of clinical research studies
Arlington, VA (PRWEB) May 29, 2012
During the MAGI conference on May 20th, 2012 in Arlington, Virginia an entire session was devoted to dual enrollment in clinical trials and the professional research subject including the concerns surrounding clinical research safety and data quality. Mitchell Efros MD FACS spoke to the challenges detecting these individuals in clinical trials and thwarting their participation in multiple trials simultaneously or commencing a new trial prior to the determined safe washout period. Dr. Mitchell Efros, CEO of Verified Clinical Trials (VCT), described methods to detect professional research subjects and dual enrollment by use of the unified clinical trial database registry that VCT offers as a means to discover these individuals and improve clinical trial research subject safety and data quality. Verified Clinical Trials (VCT) is the largest North American clinical trials database registry. Because VCT is 100% web based, the system is scalable and affordable without the need to purchase and install software or hardware. This allows VCT to focus on both early phase and late phase trials improving the coverage and worth of the entire database.
Attending the session were members of IRB, CRO's, research sites, and pharmaceutical companies. During open discussions following the presentation many audience members shared their experiences and concerns regarding trials that are conducted without the use of such a registry. It was agreed that increased vigilance and use of a scalable all inclusive clinical trials database registry, such as Verified Clinical Trials, were essential to improving safety and data quality.
Mitchell Efros MD FACS, the CEO of VCT, stated "It is apparent that the professional research subject is not unique to early phase trials and that an effective clinical trials database registry must include all phases of clinical research studies. By excluding later phase trials we are leaving the door open to have these same subjects injure themselves and dirty the data." He further added "the Verified Clinical Trials network includes many of the world's largest CRO's and many of the major pharmaceutical companies as well. The Verified Clinical Trials database registry continues to grow rapidly. Because we are completely web based without any need for hardware or software installation we can instantly be deployed across North America without the need to even actually visit the site or unit. This allows us to include all sites in all studies and thereby make the registry complete in a cost effective manner."
About Verified Clinical Trials
Verified Clinical Trials is a forward thinking company developed by experts in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world's leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry that is fully web based and designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally and globally. Verified Clinical Trials is a HIPAA- and 21 CFR part 11- compliant online subject registry to anonymously and securely validate subjects and prevent dual enrollment in multiple concurrent research studies. Verified Clinical Trials offers numerous other value-added services to the clinical research site, CRO, and pharmaceutical sponsor, that prove invaluable with regards to financial and legal issues and liabilities. To RSVP or for more information, visit http://www.verifiedclinicaltrials.com.
Verified Clinical Trials Contact Info
Kerri Weingard, ANP, Chief Operating Officer
Verified Clinical Trials +1 516 998-7499